SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Historical Holders from Q1 2014 to Q3 2025

Symbol: SGMO on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 294,683,714
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 62,599,661
Holdings value: $42,142,133
% of all portfolios: 0%
Number of holders: 111
Number of buys: 59
Number of sells: -34
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
WASATCH ADVISORS LP	2.1%	-62%	$4,167,240	-$3,664,854	6,188,358	-46.8%	Wasatch Advisors LP	30 Sep 2025

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	62,599,661	$42,142,133	-$4,085,083	$742,471	$643,403	$0.6734	111
2025 Q2	73,226,420	$39,627,128	-$1,366,580	$426,288	$596,648	$0.5413	110
2025 Q1	52,557,554	$34,474,526	-$6,973,632	$1,205,290	$1,447,309	$0.6558	118
2024 Q4	61,547,249	$62,817,305	+$5,840,058	$1,822,842	$1,397,910	$1.02	125
2024 Q3	55,892,914	$48,377,748	-$13,237,737	$1,014,241	$500,291	$0.8661	100
2024 Q2	86,880,740	$31,098,958	-$5,513,248	$55,892	$12,857	$0.3583	126
2024 Q1	100,425,667	$67,257,419	+$9,590,265	$44,099	$23,789	$0.6702	125
2023 Q4	86,966,421	$47,198,697	-$9,265,269	$28,034	$40,364	$0.5433	129
2023 Q3	102,314,735	$61,341,591	-$4,250,211	$59,380	$48,467	$0.5998	131
2023 Q2	105,778,869	$137,125,383	-$10,782,201	$56,810	$74,360	$1.3	149
2023 Q1	112,297,853	$197,560,841	+$11,997,591	$74,976	$193,872	$1.76	178
2022 Q4	104,011,293	$326,153,436	+$18,050,138	$428,924	$1,001,618	$3.14	179
2022 Q3	97,395,258	$477,415,251	+$38,514,658	$1,417,000	$2,057,030	$4.9	189
2022 Q2	89,662,495	$371,001,039	+$44,113,066	$1,143,000	$2,145,000	$4.14	174
2022 Q1	79,972,857	$465,159,583	+$13,325,276	$1,875,000	$2,975,000	$5.81	184
2021 Q4	76,880,593	$576,854,799	+$14,652,510	$4,667,000	$5,134,000	$7.5	178
2021 Q3	75,230,827	$678,917,887	-$11,341,782	$6,477,000	$8,186,000	$9.01	182
2021 Q2	76,183,727	$911,820,230	-$39,619,833	$10,155,000	$12,793,000	$11.97	189
2021 Q1	79,366,997	$993,813,520	+$8,744,496	$11,192,000	$15,986,000	$12.53	189
2020 Q4	78,279,519	$1,221,988,081	-$2,887,670	$18,630,000	$35,315,000	$15.6	215
2020 Q3	81,633,901	$772,262,574	+$39,692,524	$9,456,000	$11,468,000	$9.45	203
2020 Q2	77,064,448	$690,282,893	+$38,360,714	$8,221,000	$10,864,000	$8.96	197
2020 Q1	74,003,681	$471,429,640	-$44,160,048	$5,092,000	$6,329,000	$6.37	175
2019 Q4	78,484,613	$656,787,904	-$35,488,595	$11,337,000	$5,116,000	$8.37	187
2019 Q3	82,109,589	$743,984,330	+$18,180,888	$10,288,000	$11,764,000	$9.05	178
2019 Q2	79,874,675	$860,158,811	+$188,076,135	$13,871,000	$21,036,000	$10.77	178
2019 Q1	65,891,322	$628,583,823	+$8,491,929	$12,941,000	$17,750,000	$9.54	178
2018 Q4	63,962,974	$734,063,851	-$24,514,588	$17,126,000	$16,092,000	$11.48	189
2018 Q3	64,628,739	$1,095,486,294	+$6,279,681	$25,972,000	$29,563,000	$16.95	214
2018 Q2	64,727,770	$919,122,586	+$101,709,560	$20,704,000	$19,389,000	$14.2	206
2018 Q1	57,191,865	$1,086,683,045	+$32,050,241	$20,663,000	$16,471,000	$19	205
2017 Q4	55,555,574	$911,135,543	+$36,567,117	$16,249,000	$21,977,000	$16.4	167
2017 Q3	54,652,539	$819,732,570	+$37,421,908	$10,297,000	$12,393,000	$15	147
2017 Q2	53,038,835	$466,764,979	+$100,856,480	$7,044,000	$7,864,000	$8.8	143
2017 Q1	41,889,756	$217,701,771	+$36,392,442	$1,672,000	$1,561,000	$5.2	115
2016 Q4	41,299,445	$125,949,665	-$12,015,817	$612,000	$977,000	$3.05	120
2016 Q3	43,952,613	$203,488,438	-$12,236,220	$793,000	$2,066,000	$4.63	121
2016 Q2	46,220,859	$267,610,930	-$15,550,987	$748,000	$1,751,000	$5.79	136
2016 Q1	48,689,873	$292,366,107	-$4,019,351	$664,000	$1,571,000	$6.05	142
2015 Q4	49,096,342	$448,268,385	-$26,270,998	$1,937,000	$24,798,000	$9.13	139
2015 Q3	52,669,346	$297,043,899	-$28,205,503	$1,859,000	$15,422,000	$5.64	140
2015 Q2	50,554,743	$560,557,135	-$37,822,320	$2,842,000	$128,265,000	$11.09	156
2015 Q1	52,645,653	$825,232,264	+$55,231,033	$6,844,000	$180,486,000	$15.68	167
2014 Q4	49,165,950	$747,418,239	+$7,297,640	$5,569,000	$190,059,000	$15.21	157
2014 Q3	48,823,503	$526,594,567	-$9,059,452	$4,017,000	$134,220,000	$10.78	157
2014 Q2	48,883,624	$746,320,055	-$18,445,491	$5,969,000	$179,278,000	$15.27	154
2014 Q1	48,216,512	$871,455,782	+$52,843,003	$19,469,000	$224,158,000	$18.08	144